Garheng Kong, MD. PhD.

Garheng Kong, MD, PhD

Independent, Non-executive Board Member
Garheng Kong founded and has served as managing partner of HealthQuest Capital, a healthcare venture growth fund, since 2013. He brings more than 25 years of clinical, technical, and business experience in creating and building high-growth and innovation- based healthcare businesses.

He currently serves on the board of directors of Venus Concept, Alimera Sciences, Inc., and Laboratory Corporation of America Holdings. Dr. Kong previously served as the Chairman of the Board of Strongbridge BioPharma until its acquisition by Xeris Pharmaceuticals. He also served on the board of directors of Histogenics Corporation, and Avedro, Inc. Dr. Kong’s early career included positions at GlaxoSmithKline, McKinsey, and TherOx before he started his investing career.

Dr. Kong earned his MD, PhD, and MBA from Duke University and received a BS in chemical engineering and a BS in biological sciences from Stanford University.

Committee Roles:
Member of the Audit Committee